The Annual General Meeting of Shareholders of BioPorto A/S will be held on

Tuesday, April 17, 2012, at 3:00 p.m. at the Company’s address, Grusbakken 8,
DK-2820 Gentofte, Denmark 



With the following agenda:



1.       Report on the Company’s activities during the past financial year;

2.       Presentation of the Annual Report with annual accounts endorsed by

Management and Auditor, including proposal for the use of profit or coverage of
deficit and grant of discharge for the Management, for approval; 

3.       Approval of board fee

4.       Election of board members and possibly deputy members;

          All board members are up for election. Carsten Lønfeldt, Peter
Nordkild, Niels T. Foged 

and Marianne Weile all stand for re-election.

5.       Election of Auditor and possibly of a deputy Auditor;

The Board of Directors proposes the re-election of Deloitte;

6.       Proposals from the Board of Directors:



a.  Proposal to the Board be authorized for a period of 18 months after the
Annual General Meeting to let the company buy back  its own shares up to 10% of
the then remaining shares. 

b. Proposal for the authorization in article § 16 to increase the share capital
to be adjusted according to the Danish Business Authority's new practice, so
that the authority is divided into two authorizations to increase share capital
with and without pre-emption rights for existing shareholders. In addition, the
board proposes that the authorizations are extended to 17 April 2017, with a
maximum increase of DKK 80 million corresponding to the balance under the
current authorization. 

c. Proposal for the authorization in article § 17 to issue convertible debt
instruments capital to be adjusted according to the Danish Business Authority's
new practice, so that the authority is divided into two authorizations to issue
convertible debt instruments with and without preemptive rights for existing
shareholders. In addition, the board proposes that the authorizations are
extended to 17 April 2017, with a maximum increase of DKK 36.050.000
corresponding to the balance under the current authorization. 

d. Proposed changes to the Company Articles:



  1. Article 6, paragraph 3: 

The Board proposes that the provision be deleted, so that shareholders and
others who have requested to receive material relating to the general meeting,
no longer need to renew the application every 3 years. 

  1. Article 7, paragraph 2: 

The Board proposes that the provision be adapted so that it follows the wording
of the Companies Act § 84 

  1. Article 8, paragraph 3: 

The Board proposes that the wording be modernized and that the consideration of
proposals from the board and shareholders, including a proposal authorizing the
Company to acquire own shares, will be on the agenda for each AGM 

  1. Article 12, paragraph 4: 

The Board proposes that it is apparent  that the General Meeting determines the
remuneration of all board members, including any employee representatives 


7.                   Any other business.

See attached document for further details


         Further information:
         Gry Husby Larsen, Corporate Legal Counsel
         Tel. no. (+45) 45 29 00 00, e-mail investor@bioporto.com